{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T12:16:25Z","timestamp":1766060185337,"version":"3.48.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005760","name":"University of Gothenburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005760","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Accurate diagnosis of oral mucositis (OM) is essential for effective management and plays a critical role in ensuring reliable outcomes in clinical trials evaluating OM-prevention and treatment strategies. Currently, no evidence-based guidelines specify which clinical profession should be primarily responsible for OM assessments in patients undergoing high-dose chemotherapy. In most Scandinavian countries, nurses perform daily OM assessments, while dentists specialized in orofacial medicine (considered the gold standard) conduct supplementary evaluations several times per week. However, the concordance between nurses\u2019 assessments and those conducted by dentists specialized in orofacial medicine remains unclear. Therefore, this study aimed to evaluate the interrater reliability in of OM assessments between these two professions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study utilized data from a randomized, blinded, multicenter, parallel-group, phase 3 trial conducted at five university hospitals in Sweden and Norway. A total of 127 patients aged 18 years or older, diagnosed with multiple myeloma or lymphoma, and scheduled to receive high-dose conditioning chemotherapy in preparation for hematopoietic stem cell transplantation, were included. The primary objective was to evaluate the interrater reliability of OM assessments across all severity grades using the World Health Organization (WHO) oral toxicity scale (grades 0\u20134). The secondary objective was to evaluate the interrater reliability of OM assessments across all severity grades at each individual study site.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Overall interrater reliability between nurses and dentists specialized in orofacial was found to be fair for OM of any grade (\u03ba\u2009=\u20090.211,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). However, agreement levels at individual study sites ranged from no agreement to fair agreement.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The interrater reliability in the assessment of oral mucositis between dentists specialized in orofacial medicine and nurses ranged from no-, to fair agreement. This highlights the need for targeted interventions to improve nurses' assessment skills or to integrate a specialized dentist as a permanent member of the multidisciplinary team in oncology and hematology settings.<\/jats:p>\n                    <jats:p>\n                      <jats:bold>Trial registration<\/jats:bold>\n                      This study is based on data from a previously registered clinical trial (ClinicalTrials.gov; Identifier: NCT03203733, Registered on November 20, 2020).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-025-14670-3","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T16:54:41Z","timestamp":1765990481000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Interrater reliability in the assessment of oral mucositis among patients receiving high-dose chemotherapy: a multicenter comparison between specialized dentists and registered nurses"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5090-1788","authenticated-orcid":false,"given":"Aram","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6041-233X","authenticated-orcid":false,"given":"Dilav","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8231-5646","authenticated-orcid":false,"given":"Hanna","family":"Mavandadipur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5660-1348","authenticated-orcid":false,"given":"Java","family":"Walladbegi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"key":"14670_CR1","doi-asserted-by":"crossref","unstructured":"Peterson DE, Bensadoun RJ, Roila F, Group EGW, editors. Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines. Ann Oncol. 2011;22:78\u201384.","DOI":"10.1093\/annonc\/mdr391"},{"key":"14670_CR2","doi-asserted-by":"crossref","unstructured":"Sonis ST. Oral mucositis. In: Sonis ST, editor. Oral Mucositis. London: Springer Healthcare; 2012. pp. 2\u20135.","DOI":"10.1007\/978-1-907673-46-7"},{"key":"14670_CR3","first-page":"17","volume":"2019","author":"RV Lalla","year":"2019","unstructured":"Lalla RV, Brennan MT, Gordon SM, Sonis ST, Rosenthal DI, Keefe DM. Oral mucositis due to High-Dose chemotherapy and\/or head and neck radiation therapy. J Natl Cancer Inst Monogr. 2019;2019:17\u201324.","journal-title":"J Natl Cancer Inst Monogr"},{"key":"14670_CR4","first-page":"3949","volume":"27","author":"CHL Hong","year":"2019","unstructured":"Hong CHL, Gueiros LA, Fulton JS, Cheng KKF, Kandwal A, Galiti D, et al. Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer. 2019;27:3949\u201367.","journal-title":"Support Care Cancer"},{"key":"14670_CR5","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3747\/co.26.5033","volume":"26","author":"A Bazinet","year":"2019","unstructured":"Bazinet A, Popradi G. A general practitioner\u2019s guide to hematopoietic stem-cell transplantation. Curr Oncol. 2019;26:187\u201391.","journal-title":"Curr Oncol"},{"key":"14670_CR6","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1016\/j.bbmt.2015.07.032","volume":"21","author":"NS Majhail","year":"2015","unstructured":"Majhail NS, Farnia SH, Carpenter PA, Champlin RE, Crawford S, Marks DI, et al. Indications for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American society for blood and marrow transplantation. Biol Blood Marrow Transpl. 2015;21:1863\u20139.","journal-title":"Biol Blood Marrow Transpl"},{"key":"14670_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12032-023-01954-6","volume":"40","author":"LSH Brianna","year":"2023","unstructured":"Brianna LSH. Chemotherapy: how to reduce its adverse effects while maintaining the potency? Med Oncol. 2023;40:1\u201313.","journal-title":"Med Oncol"},{"key":"14670_CR8","first-page":"57","volume":"72","author":"S Elad","year":"2022","unstructured":"Elad S, Yarom N, Zadik Y, Kuten-Shorrer M, Sonis ST. The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies. CA Cancer J Clin. 2022;72:57\u201377.","journal-title":"CA Cancer J Clin"},{"key":"14670_CR9","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cden.2007.10.002","volume":"52","author":"RV Lalla","year":"2008","unstructured":"Lalla RV, Sonis ST, Peterson DE. Management of oral mucositis in patients who have cancer. Dent Clin North Am. 2008;52:61\u201377.","journal-title":"Dent Clin North Am"},{"key":"14670_CR10","unstructured":"World Health Organization. WHO handbook for reporting results of cancer treatments. Geneva: World Health Organization. 1979. pp. 15\u201322. Available from: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/37200\/WHO_OFFSET_48.pdf?sequence=1&isAllowed=y . Accessed 1 May 2025."},{"key":"14670_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00280-017-3434-2","volume":"80","author":"J Walladbegi","year":"2017","unstructured":"Walladbegi J, Gellerstedt M, Svanberg A, Jontell M. Correction to: Innovative intraoral cooling device better tolerated and equally effective as ice cooling. Cancer Chemother Pharmacol. 2017;80:1\u20138.","journal-title":"Cancer Chemother Pharmacol"},{"key":"14670_CR12","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/s41409-021-01512-6","volume":"57","author":"J Walladbegi","year":"2022","unstructured":"Walladbegi J, Henriksson R, Tavelin B, Svanberg A, Larfors G, Jadersten M, et al. Efficacy of a novel device for cryoprevention of oral mucositis: a randomized, blinded, multicenter, parallel group, phase 3 trial. Bone Marrow Transpl. 2022;57:191\u20137.","journal-title":"Bone Marrow Transpl"},{"key":"14670_CR13","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","volume":"333","author":"T Philip","year":"1995","unstructured":"Philip T, Guglielmi C, Hagenbeek A, Somers R, van der Lelie H, Bron D, et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin\u2019s lymphoma. N Engl J Med. 1995;333:1540\u20135.","journal-title":"N Engl J Med"},{"key":"14670_CR14","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/sj.bmt.1700913","volume":"20","author":"MD Caballero","year":"1997","unstructured":"Caballero MD, Rubio V, Rifon J, Heras I, Garcia-Sanz R, Vazquez L, et al. BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factors. Bone Marrow Transpl. 1997;20:451\u20138.","journal-title":"Bone Marrow Transpl"},{"key":"14670_CR15","doi-asserted-by":"publisher","first-page":"276","DOI":"10.11613\/BM.2012.031","volume":"22","author":"ML McHugh","year":"2012","unstructured":"McHugh ML. Interrater reliability: the kappa statistic. Biochem Med (Zagreb). 2012;22:276\u201382.","journal-title":"Biochem Med (Zagreb)"},{"key":"14670_CR16","first-page":"2103","volume":"85","author":"ST Sonis","year":"1999","unstructured":"Sonis ST, Eilers JP, Epstein JB, LeVeque FG, Liggett WH Jr., Mulagha MT, et al. Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis Study Group Cancer. 1999;85:2103\u201313.","journal-title":"Mucositis Study Group Cancer"},{"key":"14670_CR17","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.ejon.2008.03.002","volume":"12","author":"CM Potting","year":"2008","unstructured":"Potting CM, Mank A, Blijlevens NM, Donnelly JP, van Achterberg T. Providing oral care in haematological oncology patients: nurses\u2019 knowledge and skills. Eur J Oncol Nurs. 2008;12:291\u20138.","journal-title":"Eur J Oncol Nurs"},{"key":"14670_CR18","first-page":"420","volume":"18","author":"TJ Huang","year":"2020","unstructured":"Huang TJ, Mu PF, Chen MB, Florczak K. Prevention and treatment of oral mucositis among cancer patients in the hematology-oncology setting: a best practice implementation project. JBI Evid Implement. 2020;18:420\u201330.","journal-title":"JBI Evid Implement"},{"key":"14670_CR19","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1016\/j.ejca.2005.04.030","volume":"41","author":"MA Stokman","year":"2005","unstructured":"Stokman MA, Sonis ST, Dijkstra PU, Burgerhof JG, Spijkervet FK. Assessment of oral mucositis in clinical trials: impact of training on evaluators in a multi-centre trial. Eur J Cancer. 2005;41:1735\u20138.","journal-title":"Eur J Cancer"},{"key":"14670_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-020-01715-7","volume":"39","author":"C Pulito","year":"2020","unstructured":"Pulito C, Cristaudo A, Porta C, Zapperi S, Blandino G, Morrone A, et al. Oral mucositis: the hidden side of cancer therapy. J Exp Clin Cancer Res. 2020;39:1\u201315.","journal-title":"J Exp Clin Cancer Res"},{"key":"14670_CR21","first-page":"9549","volume":"30","author":"F Gundogdu","year":"2022","unstructured":"Gundogdu F, Sayar S. Oncology nursing practices in the management of chemotherapy-related oral mucositis in accordance with evidence-based guidelines: a descriptive and cross-sectional study. Support Care Cancer. 2022;30:9549\u201357.","journal-title":"Support Care Cancer"},{"key":"14670_CR22","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1177\/17449871211016524","volume":"26","author":"M Doshi","year":"2021","unstructured":"Doshi M, Mann J, Quentin L, Morton-Holtham L, Eaton KA. Mouth care training and practice: a survey of nursing staff working in National health service hospitals in England. J Res Nurs. 2021;26:574\u201390.","journal-title":"J Res Nurs"},{"key":"14670_CR23","first-page":"283","volume":"6","author":"L Abu Sharour","year":"2019","unstructured":"Abu Sharour L. A cross-sectional study on oncology nurses\u2019 knowledge and practice of oral mucositis among cancer patients in Jordan. Int J Nurs Sci. 2019;6:283\u20137.","journal-title":"Int J Nurs Sci"},{"key":"14670_CR24","doi-asserted-by":"publisher","first-page":"7292","DOI":"10.1002\/nop2.1982","volume":"10","author":"BM Raymond","year":"2023","unstructured":"Raymond BM, Agyeman-Yeboah J. Nurses\u2019 knowledge on assessment and management of cancer therapy-associated oral mucositis. Nurs Open. 2023;10:7292\u2013300.","journal-title":"Nurs Open"},{"key":"14670_CR25","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.apnr.2010.12.002","volume":"25","author":"EY Chan","year":"2012","unstructured":"Chan EY, Hui-Ling Ng I. Oral care practices among critical care nurses in singapore: a questionnaire survey. Appl Nurs Res. 2012;25:197\u2013204.","journal-title":"Appl Nurs Res"},{"key":"#cr-split#-14670_CR26.1","unstructured":"Socialstyrelsen. Socialstyrelsens f\u00f6reskrifter och allm\u00e4nna r\u00e5d om tandl\u00e4karnas specialiseringstj\u00e4nstg\u00f6ring (HSLF-FS 2017:77). Stockholm: Socialstyrelsen"},{"key":"#cr-split#-14670_CR26.2","unstructured":"2017. pp. 56-67. Available from: https:\/\/www.socialstyrelsen.se\/globalassets\/sharepoint-dokument\/artikelkatalog\/foreskrifter-och-allmanna-rad\/2017-12-40.pdf. Accessed 1 May 2025."},{"key":"14670_CR27","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1080\/1042819031000083028","volume":"44","author":"E Jantunen","year":"2003","unstructured":"Jantunen E, Kuittinen T, Nousiainen T. BEAC or BEAM for high-dose therapy in patients with non-Hodgkin\u2019s lymphoma? A single centre analysis on toxicity and efficacy. Leuk Lymphoma. 2003;44:1151\u20138.","journal-title":"Leuk Lymphoma"},{"key":"14670_CR28","first-page":"2449","volume":"28","author":"MEP Correa","year":"2020","unstructured":"Correa MEP, Cheng KKF, Chiang K, Kandwal A, Loprinzi CL, Mori T, et al. Systematic review of oral cryotherapy for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer. 2020;28:2449\u201356.","journal-title":"Support Care Cancer"},{"key":"14670_CR29","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1002\/cncr.20162","volume":"100","author":"ST Sonis","year":"2004","unstructured":"Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, et al. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer. 2004;100:1995\u20132025.","journal-title":"Cancer"},{"key":"14670_CR30","first-page":"228","volume":"15","author":"CM Potting","year":"2006","unstructured":"Potting CM, Blijlevens NA, Donnelly JP, Feuth T, van Achterberg T. A scoring system for the assessment of oral mucositis in daily nursing practice. Eur J Cancer Care (Engl). 2006;15:228\u201334.","journal-title":"Eur J Cancer Care (Engl)"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14670-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14670-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14670-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T12:13:05Z","timestamp":1766059985000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-025-14670-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14670"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14670-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"type":"electronic","value":"1471-2407"}],"subject":[],"published":{"date-parts":[[2025,12,17]]},"assertion":[{"value":"9 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures involving human participants in this study were conducted in accordance with the ethical principles outlined in the World Medical Association (WMA) Declaration of Helsinki (Fortaleza, October 2013). The study protocol was reviewed and approved by the Swedish Ethical Review Authority, Gothenburg, Sweden (Ref. No. 586\u2009\u2212\u200915), and the Regional Committee for Medical and Health Research Ethics, Oslo, Norway (Ref. No. 2018\/1653). Written informed consent was obtained from all patients prior to enrollment. Patients were informed of their right to withdraw from the study at any time, without any consequences and without the need to provide a reason.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1874"}}